istock-625061004_warchicompliance

Warchi /iStockphoto.com

19 December 2017Big Pharma

European Commission closes Roche investigation

The European Commission has closed an investigation into Roche which centred on the company’s pharmacovigilance duties.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

EMA concludes drug monitoring probe against Roche

5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.

More on this story

EMA concludes drug monitoring probe against Roche

5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.

More on this story

EMA concludes drug monitoring probe against Roche

5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers